Adverse events for the AB023 phase 2 clinical trial
| Adverse event . | Severity . | Treatment group . | Onset . |
|---|---|---|---|
| Dialysis circuit hypotension | Grade 3 | 0.25 mg/kg | Predose |
| Viral gastroenteritis | Grade 2 | 0.25 mg/kg | Postdose |
| Viral gastroenteritis | Grade 2 | 0.25 mg/kg | Postdose |
| Viral gastroenteritis | Grade 2 | Placebo | Postdose |
| Vomiting | Grade 1 | 0.5 mg/kg | Predose |
| Vomiting | Grade 1 | N/A early term | Predose |
| Diarrhea | Grade 1 | 0.5 mg/kg | Predose |
| Diarrhea | Grade 1 | Placebo | Predose |
| Diarrhea | Grade 1 | N/A early term | Predose |
| Diarrhea | Grade 1 | Placebo | Predose |
| Nausea | Grade 1 | 0.5 mg/kg | Predose |
| Nausea | Grade 1 | N/A early term | Predose |
| Adverse event . | Severity . | Treatment group . | Onset . |
|---|---|---|---|
| Dialysis circuit hypotension | Grade 3 | 0.25 mg/kg | Predose |
| Viral gastroenteritis | Grade 2 | 0.25 mg/kg | Postdose |
| Viral gastroenteritis | Grade 2 | 0.25 mg/kg | Postdose |
| Viral gastroenteritis | Grade 2 | Placebo | Postdose |
| Vomiting | Grade 1 | 0.5 mg/kg | Predose |
| Vomiting | Grade 1 | N/A early term | Predose |
| Diarrhea | Grade 1 | 0.5 mg/kg | Predose |
| Diarrhea | Grade 1 | Placebo | Predose |
| Diarrhea | Grade 1 | N/A early term | Predose |
| Diarrhea | Grade 1 | Placebo | Predose |
| Nausea | Grade 1 | 0.5 mg/kg | Predose |
| Nausea | Grade 1 | N/A early term | Predose |
All adverse events were unrelated to the study drug.
N/A, not applicable; term, termination.